Veracyte Ownership | Who Owns Veracyte?


OverviewForecastRevenueFinancialsChartTranscripts

Veracyte Ownership Summary


Veracyte is owned by 109.83% institutional investors, 0.81% insiders. Blackrock is the largest institutional shareholder, holding 10.42% of VCYT shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 3.87% of its assets in Veracyte shares.

VCYT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVeracyte109.83%0.81%-10.64%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock7.79M10.42%$168.88M
Vanguard group7.50M10.03%$162.46M
Wellington management group llp6.88M9.20%$149.01M
Ark investment management6.81M9.11%$147.56M
Dimensional fund advisors lp3.46M4.63%$75.01M
Sumitomo mitsui trust3.18M4.26%$68.95M
Nikko asset management americas3.18M4.26%$68.91M
Champlain investment partners3.17M4.24%$68.64M
Artisan partners limited partnership3.06M4.10%$66.39M
Arrowmark colorado3.00M4.01%$64.96M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Perkins capital management98.83K2.02%$2.14M
Silverarc capital management282.25K1.44%$6.12M
Casdin capital857.90K1.42%$18.59M
Ark investment management6.81M1.31%$147.56M
Efg asset management (north america)243.88K0.92%$5.28M
Virtus investment advisers49.81K0.91%$1.08M
Oberweis asset management inc/654.10K0.87%$14.17M
Granite investment partners934.99K0.84%$20.26M
Nikko asset management americas3.18M0.80%$68.91M
Arrowmark colorado3.00M0.77%$64.96M

Top Buyers

HolderShares% AssetsChange
Exoduspoint capital management, lp798.64K0.12%650.65K
Blackrock7.79M0.00%581.69K
William blair investment management1.24M0.07%500.02K
Champlain investment partners3.17M0.42%470.07K
Aegon asset management uk759.25K0.23%358.00K

Top Sellers

HolderShares% AssetsChange
State street2.91M0.00%-1.42M
Fiera capital---625.54K
Point72 asset management---566.63K
Wellington management group llp6.88M0.03%-491.28K
Mirae asset global investments2.28K0.00%-463.71K

New Positions

HolderShares% AssetsChangeValue
Mirae asset global etfs239.57K0.01%239.57K$5.19M
Bridgeway capital management199.40K0.10%199.40K$4.32M
Norges bank156.40K0.00%156.40K$3.39M
Cinctive capital management lp104.67K0.11%104.67K$2.27M
Corebridge financial41.34K0.00%41.34K$895.88K

Sold Out

HolderChange
Tfc financial management-1.00
Opal wealth advisors-13.00
First command advisory services-20.00
Covestor-22.00
Park place capital-24.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024239-2.05%82,106,4620.48%1090.92%117-21.48%8224.24%
Mar 31, 2024244-3.17%81,711,2235.83%1090.98%14929.57%66-37.14%
Dec 31, 20232526.33%77,206,7751.07%1050.96%115-8.73%10536.36%
Sep 30, 20232372.60%76,389,899-0.89%1040.93%1266.78%77-3.75%
Jun 30, 2023231-77,077,823-2.02%1060.90%118-9.23%8031.15%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
ARK Disruptive Innovation Full Composite2.97M3.87%-986.73K
ARK Innovation ETF2.92M3.81%-
Vanguard Explorer Inv2.80M3.65%-1.02M
Vanguard Total Stock Mkt Idx Inv2.45M3.16%-13.70K
iShares Russell 2000 ETF1.98M2.55%-4.44K
Nikko AM ARK Disruptive Innovation A USD1.95M2.54%-48.64K
Vanguard Small Cap Index1.92M2.48%3.75K
ARK Genomic Revolution1.72M2.24%-234.64K
ARK Genomic Revolution ETF1.64M2.14%7.91K
Champlain Small Company Fund, LLC1.51M1.94%-297.59K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 12, 2024Chambers Rebecca Chief Financial OfficerSell$585.66K
Nov 12, 2024EPSTEIN ROBERT S-Sell$574.83K
Sep 19, 2024JONES EVAN/ FA-Sell$182.26K
Sep 04, 2024Leite John Chief Commercial Officer-CLIASell$163.16K
Aug 13, 2024JONES EVAN/ FA-Sell$544.85K

Insider Transactions Trends


DateBuySell
2024 Q4-2
2024 Q3-21
2024 Q2-5
2024 Q1-1
2023 Q4--

VCYT Ownership FAQ


Who Owns Veracyte?

Veracyte shareholders are primarily institutional investors at 109.83%, followed by 0.81% insiders and -10.64% retail investors. The average institutional ownership in Veracyte's industry, Biotech Stocks , is 45.43%, which Veracyte exceeds.

Who owns the most shares of Veracyte?

Veracyte’s largest shareholders are Blackrock (7.79M shares, 10.42%), Vanguard group (7.5M shares, 10.03%), and Wellington management group llp (6.88M shares, 9.20%). Together, they hold 29.65% of Veracyte’s total shares outstanding.

Does Blackrock own Veracyte?

Yes, BlackRock owns 10.42% of Veracyte, totaling 7.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 168.88M$. In the last quarter, BlackRock increased its holdings by 581.69K shares, a 8.07% change.

Who is Veracyte’s biggest shareholder by percentage of total assets invested?

Perkins capital management is Veracyte’s biggest shareholder by percentage of total assets invested, with 2.02% of its assets in 98.83K Veracyte shares, valued at 2.14M$.

Who is the top mutual fund holder of Veracyte shares?

ARK Disruptive Innovation Full Composite is the top mutual fund holder of Veracyte shares, with 3.87% of its total shares outstanding invested in 2.97M Veracyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools